Publications scientifiques

PRINCIPALES PUBLICATIONS
DEPUIS 2019

Rates and determinants of alcohol-drinking categories in France: a general population survey.

Rolland B, de Ternay J, Haesebaert J, Delile JM, Savy M, Tubiana-Rey B, Naassila M, Lespine LF.

Eur J Pub Health 2026; 202:108428. https://doi.org/10.1093/eurpub/ckaf147.

Determinants of successful completion and short-term benefits associated with temporary alcohol abstinence during Dry January in France: A prospective cohort study.

Lespine LF, François D, Haesebaert J, Delile JM, Savy M, Naassila M, de Ternay J, Rolland B.

Prev Med. 2025; 202:108428. doi: 10.1016/j.ypmed.2025.108428.

Integrative exploration of bio-psycho-social determinants of DSM-5 severity levels of opioid use disorder: the BEBOP cohort study protocol

Lalanne L, Lutz PE, Caparros-Roissard A, Ruppert E, Waeckerle G, Scherer C, Oster F, Brand C, Henck S, Soavelo H, Ramousset C, Lebreton M, Audran M, Lazic J, Detrez V, Avril E, Merah I, Chappuy M, Meyer N, Jauffret-Roustide M, Rolland B.

BMJ Open. 2025 Oct 13;15(10):e093358.doi: 10.1136/bmjopen-2024-093358.

Longitudinal disturbances of objective sleep architecture in cocaine use disorder: A translational systematic review.

Medigue I, Catoire S, Peyron C, Geoffroy PA, Bernabeu T, Peter-Derex L, Rolland B.

Neurosci Biobehav Rev. 2025 Sep;176:106278. doi: 10.1016/j.neubiorev.2025.106278.

"Un attracteur de soins": Bringing People Into Care. Interdisciplinary Health Care Professionals' Attitudes Toward Opioid Agonist Therapy in France: a Qualitative Study with Implications for the United States.

Englander H, Rolland B, Jauffret-Roustide M.

Subst Use Addctn J. 2025; 46(3):643-653

Trend analyses and comparison of characteristics of current-, former- and never-drinkers among young adults in France from 2000 to 2021.

de Ternay J, Andler R, Gautier A, de Dinechin S, Davalos R, Rolland B, Jauffret-Roustide M.

BMC Public Health 2025; 25(1):1157. doi: 10.1186/s12889-025-22405-z

Determinants of substance use patterns in patients with narcolepsy type 1: A multi-center comparative cross-sectional study.

Peter-Derex L, Fort E, Putois B, ... , Rolland B.

Sleep Medicine 2025; 129:148-166.

A case series examining the efficacy of gabapentin as a substitution therapy for the treatment of pregabalin use disorder

Lejeune O, Chappuy M, Bailly F, Rolland B.

Am J Drug Alcohol Abuse 2025; 51(1):68-72

Conditions of sleep restoration after smoking cessation: a systematic review

Mauries S, Rolland B, Malleyvas M, Catoire S, Zehani F, Sauvage K, Davido G, Lejoyeux M, Geoffroy PA.

Sleep Med Rev 2025. https://doi.org/10.1016/j.smrv.2024.102041

Prevalence and characteristics of participants in Dry January 2024: findings from a general population survey in France.

Lespine LF, François D, Haesebaert J, Delile JM, Savy M, Tubiana-Rey B, Naassila M, de Ternay J, Rolland B.

Front Public Health. 2024; 12:1466739. doi: 10.3389/fpubh.2024.1466739.

Impact of working conditions and other determinants on the risk of substance misuse among healthcare residents: results of a cross-sectional study.

de Ternay J, Nohales L, Fort E, Pelloux S, Coste C, Leblanc P, Wallon M, Fassier JB, Rolland B.
Eur Addict Res. 2024; 1-22. doi: 10.1159/000542592

National impact of a constraining regulatory framework on pregabalin dispensations in France, 2020-2022.

de Ternay J, Meley C, Guerin P, Meige S, Grelaud N, Rolland B, Chappuy M.

Int J Drug Policy. 2024; 135:104660. doi: 10.1016/j.drugpo.2024.104660.

Compared implementation of the long-acting buprenorphine treatment buvidal in four European countries.

Rolland B, Matheson C, Kaski A, Kosim M, Roncero C, Vorspan F.

Expert Opin Drug Deliv. 2024. doi: 10.1080/17425247.2024.2369756.

Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database.

Rolland B, Hallouche N, Lada O, Rabiéga P, Fouad F, Benabadji E, Pol S.

Psychiatry Res. 2024; doi: 10.1016/j.psychres.2024.116032.

Comparing methadone policy and practice in France and the US: Implications for US policy reform.

Englander H, Chappuy M, Krawczyck N, Bratberg J, Potee R, Jauffret-Roustide M, Rolland B.

Int J Drug Policy. 2024 Jun 14:129:104487.doi: 10.1016/j.drugpo.2024.104487

Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey)

Chappuy M, Lack P, David B, Penavayre G, Thabourey D, Landulpho M, Plasse A, Icard C, Bailly F, Boutahra F, Pradat P, Maynard M, Jauffret-Roustide M, de Ternay J, Rolland B.

Harm Reduct J. 2023 Oct 16;20(1):149. doi: 10.1186/s12954-023-00887-7.

Patterns and determinants of cannabis use in youth visiting an urban emergency department in France.

Touali R, Chappuy M, De Ternay J, Berger-Vergiat A, Haesebaert J, Tazarourte K, Michel P, Rolland B.

J Addict Dis. 2023 Dec 4:1-9.

Willingness to use a drug consumption room among people who use drugs in Lyon, France, a city with no open scene of drug use (the TRABOUL survey).

Chappuy M, Lack P, David B, Penavayre G, Thabourey D, Landulpho M, Plasse A, Icard C, Bailly F, Boutahra F, Pradat P, Maynard M, Jauffret-Roustide M, de Ternay J, Rolland B..
Harm Reduct J. 2023 Oct 16;20(1):149. doi: 10.1186/s12954-023-00887-7.

Five challenges in implementing cognitive remediation for patients with substance use disorders in clinical settings.

Maurage P, Rolland B, Pitel AL, d'Hondt F.

Neuropsychol Rev. 2024; 34(3):974-984. doi: 10.1007/s11065-023-09623-1

Association between cannabis use and symptom dimensions in schizophrenia spectrum disorders: an individual participant data meta-analysis on 3053 individuals.

Argote M, Sescousse G, Brunelin J, [...], Nourredine M, Rolland B.

eClinicalMedicine 2023; 8:64:102199.doi: 10.1016/j.eclinm.2023.102199.

Compared Profile of Late-Onset Versus Childhood-Onset ADHD: A Case-Control Study Among Treatment-Seeking Adult Patients.

Jurek L, Montègue S, Larrieu A, Icard C, Rolland B.

J Atten Disord. 2023; 11:10870547231191756. doi: 10.1177/10870547231191756.

Education and Training in Addiction Medicine and Psychology across Europe: A EUFAS Survey.

Bramness JG, Leonhardt M, Dom G, Batalla A, Flórez Menéndez G, Mann K, Wurst FM, Wojnar M, Drummond C, Scafato E, Gual A, Ribeiro CM, Cottencin O, Frischknecht U, Rolland B.

Eur Addict Res. 2023; 9:1-11. doi: 10.1159/000531502.

Profile of patients with a positive HCV viral load in a large French psychiatric hospital (2019-2021): A case-control study.

Torres C, Bauer G, Aubriet S, Scholtes C, Bailly F, Maynard-Muet M, Pradat P, Pillot-Meunier F, Lespine LF, Rolland B.

J Viral Hepat. 2023; 30(10):830-833. doi: 10.1111/jvh.13875.

Screening problematic use of substances among young subjects attending an emergency department, and subsequent treatment seeking.

Touali R, Chappuy M, Berger-Vergiat A, Deletoille M, Ragonnet D, Rochet T, Poulet E, Tazarourte K, Haesebaert J, Michel P, Rolland B. Encéphale. 2023; doi: 10.1016/j.encep.2023.04.009.

Effect of lockdown on sleep-wake rhythm and alcohol use.

Mauries S, Bertrand L, Rolland B, Stern E, Tebeka S, Davido G, Frija-Masson J, D'ortho MP, Lejoyeux M, Geoffroy PA.

Chronobiol Int. 2023; 40(3):300-309.

Capture d’écran 2022-11-20 à 20.00.00.png

Insufficient physical activity is a global marker of severity in alcohol use disorder: results from a cross-sectional study in 382 treatment-seeking patients

de Ternay J, Larrieu A, Sauvestre L, Montègue S, Guénin M, Icard C, Rolland B.

Nutrients. 2022; 14(23), 4958; doi.org/10.3390/nu14234958

Longitudinal determinants of insomnia among patients with alcohol use disorder.

Bolstad I, Toft H, Lien L, Moe JS, Rolland B, Bramness JG.
Alcohol. 2022; S0741-8329(22)00116-1. doi: 10.1016/j.alcohol.2022.11.002.

Are Brain Responses to Emotion a Reliable Endophenotype of Schizophrenia? An Image-Based Functional Magnetic Resonance Imaging Meta-analysis.

Fiorito AM, Aleman A, Blasi G, Bourque J, Cao H, [...], Venkatasubramanian G, Villarreal M, Wang Y, Wolf DH, Yun JY, Fakra E, Sescousse G. Biol Psychiatry. 2022; S0006-3223(22)01357-9. doi: 10.1016/j.biopsych.2022.06.013

Autonomic responses during Gambling: the Effect of Outcome Type and Sex in a large community sample of young adults.

Hultman C, Vadlin S, Rehn M, Sescousse G, Nilsson KW, Åslund C.

J Gambl Stud. 2022. doi: 10.1007/s10899-022-10118-6.

Antipsychotic prescribing practices in real-life (APPREAL study): Findings from the French National Healthcare System Database (2007–2017).

Rolland B, Dalon F, Gauthier N, Nourredine M, Bérard M, Carton L, Brousse G, Llorca PM, Jacoud F, Van Ganse E, Belhassen M. Front Psychiatry. 2022; doi.org/10.3389/fpsyt.2022.1021780

Baclofen in alcohol use disorder: An analysis of the data provided by the French "Temporary Recommendation for Use" 2014-2017 cohort.

de Beaurepaire R, Rolland B. Front Psychiatry. 2022; 13:949750.

Capture d’écran 2022-11-17 à 00.58.12.png

Association between formal thought disorder and cannabis use: a systematic review and meta-analysis.

Argote M, Sescousse G, Brunelin J, Fakra E, Nourredine M, Rolland B.

Schizophrenia (Heidelb). 2022; 8(1):78. doi: 10.1038/s41537-022-00286-0.

Adherence to opioid agonist therapy predicts uptake of direct-acting antivirals in people who use drugs: results from the French national healthcare database (the ANRS FANTASIO study).

Rolland B, Lions C, Di Beo V, Carrieri P, Authier N, Barré T, Delorme J, Mathurin P, Bailly F, Protopopescu C, Marcellin F. Harm Reduct J. 2022; 19(1):119. doi: 10.1186/s12954-022-00702-9.

Substance Use, Substance Use Disorders, and Co-Occurring Psychiatric Disorders in Recently Incarcerated Men: A Comparison with the General Population.

Fovet T, Wathelet M, Benbouriche M, Benradia I, Roelandt JL, Thomas P, d'Hondt F, Rolland B.

Eur Addict Res. 2022; 28(5):368-376. doi: 10.1159/000526079.

Lespine LF, Bramness JG, Pignon B, Vaiva G, Thomas P, Roelandt JL, Benradia I, Amad A, Geoffroy PA, Rolland B.

Arch Womens Ment Health. 2022; 25(5):895-902. doi: 10.1007/s00737-022-01253-5.

What is the potential for abuse of lisdexamfetamine in adults? A preclinical and clinical literature review and expert opinion.

Carton L, Icick R, Weibel S, Dematteis M, Kammerer E, Batisse A, Rolland B; French coordination for adult ADHD. Expert Rev Clin Pharmacol 2022; 15(8):921-925. doi: 10.1080/17512433.2022.2112950.

Management of alcohol-related liver disease: the French Association for the Study of the Liver and the French Alcohol Society clinical guidelines.

Louvet A, Trabut JB, Moreno C, Moirand R, Aubin HJ, Ntandja Wandji LC, Nourredine M, Ningarhari M, Ganne-Carrié N, Pageaux GP, Bailly F, [...], Mathurin P, Rolland B; for the Groupe collaboratif AFEF-SFA Maladie du foie liée à l'alcool. Liver Int. 2022; 42(6):1330-1343. doi: 10.1111/liv.15221.

One-month alcohol abstinence national campaigns: a scoping review of the harm reduction benefits.

de Ternay J, Leblanc P, Michel P, Benyamina A, Naassila M, Rolland B.
Harm Reduct J. 2022; 19(1):24. doi: 10.1186/s12954-022-00603-x

Proportion and conditions of use of intranasal take-home naloxone kits: A retrospective study in two French outpatient addiction centers, 2016-2020.

Chappuy M, Fezzani L, Ragonnet D, Berger A, Duvernay N, Lack P, Rolland B.
Therapies. 2022; 77(5):581-584. doi: 10.1016/j.therap.2022.01.006.

Sodium oxybate for the maintenance of abstinence in alcohol-dependent patients: An international, multicenter, randomized, double-blind, placebo-controlled trial.

Guiraud J, Addolorato G, Antonelli M, Aubin HJ, [...], Rolland B, Rotondo C, Scherrer B, Simon N, Skala K, Söderpalm B, Somaini L, Sommer WH, Spanagel R, Vassallo GA, Walter H, van den Brink W.
J Psychopharmacol. 2022; 36(10):1136-1145. doi: 10.1177/02698811221104063.

Gabapentinoid use in French most precarious populations: Insight from Lyon Permanent Access to Healthcare (PASS) units, 2016-1Q2021.

Chappuy M, Nourredine M, Clerc B, Fahmi M, Misslin P, Berthier M, Laloi L, Rolland B.

Fundam Clin Pharmacol. 2022; 36(2):448-452. doi: 10.1111/fcp.12726.

Tobacco-induced sleep disturbances: A systematic review and meta-analysis.

Catoire S, Nourredine M, Lefebvre S, Couraud S, Gronfier C, Rey R, Peter-Derex L, Geoffroy PA, Rolland B.

Sleep Med Rev. 2021; 60:101544. doi: 10.1016/j.smrv.2021.101544.

Efficacy and safety of topiramate for reducing impulsivity: A transdiagnostic systematic review and meta-analysis of a common clinical use.

Chapron SA, Nourredine M, Dondé C, Haesebaert F, Micoulaud-Franchi JA, Geoffroy PA, Rolland B.

Fundam Clin Pharmacol. 2021; 36(1):4-15. doi: 10.1111/fcp.12710.

Factors of Interest in Extended-Release Buprenorphine: Comparisons Between Incarcerated and Non-Incarcerated Patients with Opioid Use Disorder.

Chappuy M, Meroueh F, Trojak B, Bachellier J, Bendimerad P, Kosim M, Hjelmström P, Nubukpo P, Brousse G, Rolland B. Patient Prefer Adherence. 2021; 15:1259-1267. doi: 10.2147/PPA.S311674.

Validation of the French version of the Cannabis Use Disorder Identification Test-Revised and comparison with the Cannabis Abuse Screening Test for screening cannabis use disorder in a psychiatric sample.

Luquiens A, Berger-Viergat A, Larrieu A, Artigaud L, Fener C, Adamson S, Laprévote V, Rolland B.
Drug Alcohol Rev. 2021; 40(7):1334-1339. doi: 10.1111/dar.13298.

Validation of the Opioid Overdose Knowledge (OOKS) and Attitudes (OOAS) Scales in French, Spanish, and German Languages, among a Sample of Opioid Users.

Laconi S, Palma-Alvarez RF, Stöver H, Padberg C, Jamin D, Meroueh F, Chappuy M, Roncero C, Rolland B.

Eur Addict Res. 2021; 27(5):326-331. doi: 10.1159/000511770.

Determinants of interest in extended-released buprenorphine: A survey among 366 French patients treated with buprenorphine or methadone.

Rolland B, Trojak B, Nourredine M, Bachellier J, Chappuy M, Bendimerad P, Kosim M, Hjelmström P, Meroueh F, Nubukpo P, Brousse G. Drug Alcohol Depend. 2021; 220:108492. doi: 10.1016/j.drugalcdep.2020.108492.

Association of Attention-Deficit/Hyperactivity Disorder in Childhood and Adolescence With the Risk of Subsequent Psychotic Disorder: A Systematic Review and Meta-analysis.

Nourredine M, Gering A, Fourneret P, Rolland B, Falissard B, Cucherat M, Geoffray MM, Jurek L.
JAMA Psychiatry. 2021; 78(5):519-529. doi: 10.1001/jamapsychiatry.2020.4799.

Analgesic opioid use disorder in patients with chronic non-cancer pain: A holistic approach for tailored management.

Bertin C, Delage N, Rolland B, Pennel L, Fatseas M, Trouvin AP, Delorme J, Chenaf C, Authier N.

Neurosci Biobehav Rev. 2021; 121:160-174. doi.org/10.1016/j.neubiorev.2020.12.015

Efficacy and safety of topiramate in binge eating disorder: a systematic review and meta-analysis

Nourredine M, Jurek L, Auffret M, Iceta S, Grenet G, Kassai B, Cucherat M, Rolland B.

CNS Spectr. 2021; 1-22. doi: 10.1017/S1092852920001613

Clinical features and outcomes of COVID-19 patients hospitalized for psychiatric disorders: a French multi-centered prospective observational study

Dobre D, Schwan R, Jansen C, Schwitzer T, Martin O, Ligier F, Rolland B, [...], Leboyer M, Thomas P, Gorwood P, Laprevote V. Psychol Med. 2021; 1-9. doi: 10.1017/S0033291721001537.